"How Biomarkers Transform Genetic Diagnostics: A Success Story With Fabry Disease"
Join us on April 15th as we share insights into Fabry Disease and a biomarker success story that is helping to change the game of genetic diagnostics.
Throughout the webinar, Dr. Tobias Boettcher will provide an overview of how biomarkers play an essential role in early diagnosis, prediction, and therapeutic monitoring. At the end of the webinar, he will be answering all open questions you may have – opening up a platform for discussion and collaboration.
Register now as we work together to educate, raise awareness, and provide the best care possible for our Fabry Disease patients.
- Diagnostic Difficulties for Fabry Disease
- Biomarkers in the Diagnostic Setting
- Lyso-Gb3: Advantages and Drawbacks
- Clinical Cases and Lessons for the Future
- Advanced Diagnostics and Precision Medicine
Date & Time:
Thursday, April 15, 2021
3:00 p.m. CEST
See when the event will take place in your time zone.
Unable to attend the CentoTalk? By registering, you will receive a recording of the webinar even if you are unable to attend. If you encounter any problems, please contact us at webinars(at)centogene(dot)com.
Tobias Böttcher, MD
Tobias Boettcher completed his internship in Neurology at the Dept. of Neurology, University of Rostock, Germany. During this time, he received a research grant from the German Academy of Natural Sciences Leopoldina, with projects at the Dept. of Physiology/Pharmacology, Karolinska Institute, and the Dept. of Neurology, University of Goettingen. In 2005, Dr. Boettcher received his Board Certification in Neurology, and subsequently worked for four years as a Registrar Neurologist at the Dept. of Neurology, Dietrich-Bonhoeffer-Hospital, Neubrandenburg.
Since September 2017, Dr. Boettcher has worked as a Clinical Neurologist at the Outpatient Medical Center of the Johanna-Odebrecht-Stiftung, Greifswald, at the specialized Outpatient Department for Neurogenetic Diseases and LSDs. Dr. Boettcher has co-authored 48 peer-reviewed scientific publications (19 in the scope of LSDs). Since 1997, he has developed vast experience in the field of LSDs through his work in patient care (outpatient departments), basic research (Neurogenetic Laboratory, University of Rostock), and diagnostics (CENTOGENE).